Moreover, the decreased expression of CLU in the early onset of cancer progression may promote the activation of nuclear factor-κB (NF-κB) that is related to inflammatory processes and induce proliferation and invasion in advanced cancers (Bonacini et al., 2019). This evidence concerns the gene NFKB1 and cancer.